Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Hepatology (Baltimore, Md.)
|
December 27, 2023
Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis
Johannes Wiegand, Annegret Franke, Kerstin Stein, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 28, 2014
Occult interferon α-induced pulmonary granulomatosis despite continuation of treatment
Jens Schreiber, Susann Langwieler, Sandra Riedel, et al.
Annals of Hepatology
|
June 12, 2026
Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting
Annegret Franke, Tobias Müller, Kerstin Stein, et al.
World Journal of Gastroenterology
|
February 23, 2018
Predictors of functional benefit of hepatitis C therapy in a 'real-life' cohort
Niels Steinebrunner, Kerstin Stein, Catharina Sandig, et al.
Hamostaseologie
|
July 16, 2016
Interferon-free treatment of chronic hepatitis C virus infection in patients with inherited bleeding disorders
Johannes Wiegand, Ingolf Schiefke, Kerstin Stein, et al.
Journal of Clinical Medicine
|
March 8, 2018
Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism
Alexander Gutwerk, Thomas Wex, Kerstin Stein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 7, 2026
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy
Frauke Stascheit, Hannah Preßler, Kerstin Stein, et al.
European Journal of Gastroenterology & Hepatology
|
September 21, 2020
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)
Kerstin Stein, Albrecht Stoehr, Hartwig Klinker, et al.
BMC Gastroenterology
|
August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort
Niels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry
Eva Katharina Messer, David Petroff, Jörn Schattenberg, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Hepatology (Baltimore, Md.)
|
December 27, 2023
Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis
Johannes Wiegand, Annegret Franke, Kerstin Stein, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 28, 2014
Occult interferon α-induced pulmonary granulomatosis despite continuation of treatment
Jens Schreiber, Susann Langwieler, Sandra Riedel, et al.
Annals of Hepatology
|
June 12, 2026
Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting
Annegret Franke, Tobias Müller, Kerstin Stein, et al.
World Journal of Gastroenterology
|
February 23, 2018
Predictors of functional benefit of hepatitis C therapy in a 'real-life' cohort
Niels Steinebrunner, Kerstin Stein, Catharina Sandig, et al.
Hamostaseologie
|
July 16, 2016
Interferon-free treatment of chronic hepatitis C virus infection in patients with inherited bleeding disorders
Johannes Wiegand, Ingolf Schiefke, Kerstin Stein, et al.
Journal of Clinical Medicine
|
March 8, 2018
Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism
Alexander Gutwerk, Thomas Wex, Kerstin Stein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 7, 2026
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy
Frauke Stascheit, Hannah Preßler, Kerstin Stein, et al.
European Journal of Gastroenterology & Hepatology
|
September 21, 2020
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)
Kerstin Stein, Albrecht Stoehr, Hartwig Klinker, et al.
BMC Gastroenterology
|
August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort
Niels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry
Eva Katharina Messer, David Petroff, Jörn Schattenberg, et al.
Page
of 3